VAXCYTE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 116.00 USD | +1.64% |
|
+3.96% | +84.71% |
| 10/09 | Analyst recommendations: Apple, Oracle, Progressive, Dollar Tree... |  |
| 10/09 | Mizuho Boosts Price Target on Vaxcyte to $163 From $113, Maintains Outperform Rating | MT |
EPS & Dividend: Vaxcyte, Inc.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -3.02 | -1.93 | -3.44 | -4.14 | -4.481 | -5.016 | -4.988 |
| Distribution rate | - | - | - | - | - | - | - |
| Reference price 2 | 26.57 | 23.79 | 47.95 | 62.80 | 116.00 | 116.00 | 116.00 |
| Nbr of stocks (in thousands) | 50,950 | 52,785 | 78,980 | 95,154 | 1,23,697 | - | - |
| Announcement Date | 29/03/21 | 28/02/22 | 27/02/23 | 27/02/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Vaxcyte, Inc.
More events
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -25.89x | - | - | ||
| -.--% | -.--% | -244.92x | 7.631 | 10.73x | ||
| -.--% | -.--% | 30.95x | 4.259 | 8.15x | ||
| -.--% | -.--% | -529.73x | 7.407 | 14.58x | ||
| -.--% | -.--% | -50.33x | 1.358 | 5.09x | ||
| - | - | - | - | - | ||
| -.--% | -.--% | -32.6x | 6.331 | 5.35x | ||
| -.--% | -.--% | 21.82x | 3.444 | 4.31x | ||
| +2.42% | +2.64% | 12.13x | 1.883 | 2.65x | ||
| -.--% | -.--% | -14.37x | -58.290800 | 37.48x | ||
| Average | +0.27% | +0.29% | -92.55x | -3.25 | 11.04x | |
| Weighted average by Cap. | +0.10% | +0.11% | -117.44x | 3.28 | 9.75x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition